These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 33067715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Topical Tacrolimus and Mycophenolic Acid Therapy Synergizes with Low Dose Systemic Immunosuppression to Sustain Vascularized Composite Allograft Survival.
    Feturi FG, Zhang W, Erbas VE, Dong L, Sahin H, Zhang Z, Oksuz S, Spiess AM, Solari MG, Venkataramanan R, Gorantla VS.
    J Pharm Sci; 2024 Jun; 113(6):1607-1615. PubMed ID: 38309457
    [Abstract] [Full Text] [Related]

  • 3. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study.
    Fries CA, Lawson SD, Wang LC, Slaughter KV, Vemula PK, Dhayani A, Joshi N, Karp JM, Rickard RF, Gorantla VS, Davis MR.
    PLoS One; 2019 Jun; 14(1):e0210914. PubMed ID: 30677062
    [Abstract] [Full Text] [Related]

  • 4. Local Injections of Tacrolimus-loaded Hydrogel Reduce Systemic Immunosuppression-related Toxicity in Vascularized Composite Allotransplantation.
    Dzhonova DV, Olariu R, Leckenby J, Banz Y, Prost JC, Dhayani A, Vemula PK, Voegelin E, Taddeo A, Rieben R.
    Transplantation; 2018 Oct; 102(10):1684-1694. PubMed ID: 29794937
    [Abstract] [Full Text] [Related]

  • 5. A local drug delivery system prolongs graft survival by dampening T cell infiltration and neutrophil extracellular trap formation in vascularized composite allografts.
    Arenas Hoyos I, Helmer A, Yerly A, Lese I, Hirsiger S, Zhang L, Casoni D, Garcia L, Petrucci M, Hammer SE, Duckova T, Banz Y, Montani M, Constantinescu M, Vögelin E, Bordon G, Aleandri S, Prost JC, Taddeo A, Luciani P, Rieben R, Sorvillo N, Olariu R.
    Front Immunol; 2024 Oct; 15():1387945. PubMed ID: 38887281
    [Abstract] [Full Text] [Related]

  • 6. Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity.
    Feturi FG, Unadkat JV, Zhang W, Hag ME, Wang Y, Komatsu C, Grybowski D, Zhang Z, Erbas V, Sahin H, Mcclaine S, Oksuz S, Plock J, Gorantla VS, Washington KM, Solari MG, Venkataramanan R, Spiess AM.
    Pharm Res; 2022 Sep; 39(9):2179-2190. PubMed ID: 35915321
    [Abstract] [Full Text] [Related]

  • 7. The Effects of Tacrolimus on Tissue-Specific, Protein-Level Inflammatory Networks in Vascularized Composite Allotransplantation.
    Aral AM, Zamora R, Barclay D, Yin J, El-Dehaibi F, Erbas VE, Dong L, Zhang Z, Sahin H, Gorantla VS, Vodovotz Y.
    Front Immunol; 2021 Sep; 12():591154. PubMed ID: 34017323
    [Abstract] [Full Text] [Related]

  • 8. Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Nonhuman Primate Model.
    Gama AR, Ng ZY, Shanmugarajah K, Mastroianni M, Randolph MA, Lellouch AG, Kohn J, Cetrulo CL.
    J Burn Care Res; 2020 Nov 30; 41(6):1172-1178. PubMed ID: 32352521
    [Abstract] [Full Text] [Related]

  • 9. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD, Fidder SAJ, Miller DT, Furtmüller GJ, Ahmadi AR, Nägele F, Lopez J, Quan A, Budihardjo J, Lough DM, Akpinarli B, Etra JW, Vasilic D, Raimondi G, Lee WPA, Montgomery RA, Sun Z, Brandacher G.
    Transplantation; 2018 Apr 30; 102(4):593-600. PubMed ID: 29298238
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW, Lee SG, Hwang S, Kim KH, Kim WJ, Sin MH, Yoon YI, Tak EY.
    Exp Clin Transplant; 2016 Aug 30; 14(4):412-8. PubMed ID: 26976646
    [Abstract] [Full Text] [Related]

  • 12. Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation.
    David-Neto E, Romano P, Kamada Triboni AH, Ramos F, Agena F, Almeida Rezende Ebner P, Altona M, Galante NZ, Brambate Carvalhinho Lemos F.
    Transplantation; 2017 Jun 30; 101(6):1365-1372. PubMed ID: 27482958
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of inhaled nanoparticle tacrolimus in preventing rejection in an orthotopic rat lung transplant model.
    Das NA, Peters JI, Simmons JD, Wang Y, O'Donnell KP, DeArmond DT, Coalson JJ, Brooks EG, Johnson SB.
    J Thorac Cardiovasc Surg; 2017 Dec 30; 154(6):2144-2151.e1. PubMed ID: 28942970
    [Abstract] [Full Text] [Related]

  • 14. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
    Plock JA, Schnider JT, Zhang W, Schweizer R, Tsuji W, Kostereva N, Fanzio PM, Ravuri S, Solari MG, Cheng HY, Rubin PJ, Marra KG, Gorantla VS.
    Transplantation; 2015 Sep 30; 99(9):1765-73. PubMed ID: 26102613
    [Abstract] [Full Text] [Related]

  • 15. Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival.
    Sutter D, Dzhonova DV, Prost JC, Bovet C, Banz Y, Rahnfeld L, Leroux JC, Rieben R, Vögelin E, Plock JA, Luciani P, Taddeo A, Schnider JT.
    Sci Rep; 2019 Jun 25; 9(1):9269. PubMed ID: 31239498
    [Abstract] [Full Text] [Related]

  • 16. Vascularized composite allograft transplant survival in miniature swine: is MHC tolerance sufficient for acceptance of epidermis?
    Cetrulo CL, Torabi R, Scalea JR, Shimizu A, Leto Barone AA, Gillon BC, Tasaki M, Leonard DA, Cormack TA, Villani V, Randolph MA, Sachs DH, Yamada K.
    Transplantation; 2013 Dec 15; 96(11):966-74. PubMed ID: 24056624
    [Abstract] [Full Text] [Related]

  • 17. Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients.
    Riva N, Galván ME, Cáceres-Guido P, Dip M, Licciardone N, Imventarza O, Schaiquevich P, Buamscha D.
    Int J Clin Pharmacol Ther; 2017 Apr 15; 55(4):352-354. PubMed ID: 28079516
    [No Abstract] [Full Text] [Related]

  • 18. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J, del Castillo D, Cabello M, Pallardó L, Grinyó JM, Fernández AM, Brunet M.
    Transplantation; 2010 Apr 27; 89(8):994-1000. PubMed ID: 20335831
    [Abstract] [Full Text] [Related]

  • 19. Daily topical tacrolimus therapy prevents skin rejection in a rodent hind limb allograft model.
    Solari MG, Washington KM, Sacks JM, Hautz T, Unadkat JV, Horibe EK, Venkataramanan R, Larregina AT, Thomson AW, Lee WPA.
    Plast Reconstr Surg; 2009 Feb 27; 123(2 Suppl):17S-25S. PubMed ID: 19182660
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.